CRL: Charles River Laboratories International, Inc.
About
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
Current Value
$186.541 Year Return
Current Value
$186.541 Year Return
Key Details
Market Cap
$9.52B
P/E Ratio
22.98
1Y Stock Return
-3.20%
1Y Revenue Growth
-3.67%
Dividend Yield
0.00%
Price to Book
2.5
Strategies that include CRL
Stock's related to CRL
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| IQV | 73.44% | $34.73B | -7.77% | 0.00% |
| IOSP | 68.46% | $2.91B | +9.50% | 1.32% |
| VSH | 63.03% | $2.07B | -31.61% | 2.64% |
| UFPI | 61.32% | $7.78B | +17.42% | 1.01% |
| FELE | 60.45% | $4.81B | +18.43% | 0.95% |
| REZI | 60.40% | $3.84B | +62.64% | 0.00% |
| TRMB | 60.06% | $17.01B | +61.09% | 0.00% |
| AVNT | 59.93% | $4.56B | +44.78% | 2.08% |
| AIT | 59.70% | $10.24B | +65.69% | 0.56% |
| MODG | 58.61% | $1.56B | -25.89% | 0.00% |
| KMT | 58.60% | $2.17B | +21.08% | 2.88% |
| AMWD | 57.65% | $1.46B | +29.41% | 0.00% |
| EXP | 57.63% | $10.05B | +69.28% | 0.33% |
| AVTR | 57.26% | $13.42B | -0.40% | 0.00% |
| SHO | 56.97% | $2.02B | +3.53% | 3.20% |
| ASGN | 56.92% | $3.73B | -6.20% | 0.00% |
| AZTA | 56.79% | $2.00B | -28.24% | 0.00% |
| IBP | 56.64% | $5.82B | +43.55% | 0.68% |
| KBH | 56.49% | $5.71B | +46.75% | 1.21% |
| CCS | 56.34% | $2.69B | +20.00% | 1.19% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TH | 0.02% | $839.02M | -24.49% | 0.00% |
| CME | 0.06% | $82.76B | +9.21% | 1.98% |
| XBIO | 0.06% | $6.01M | +21.36% | 0.00% |
| SNY | 0.12% | $120.34B | +3.11% | 4.25% |
| KEP | 0.17% | $11.16B | +25.58% | 0.00% |
| WM | 0.22% | $87.92B | +27.58% | 1.34% |
| QNRX | -0.22% | $3.20M | -85.07% | 0.00% |
| MRK | -0.27% | $244.21B | -5.55% | 3.18% |
| PRT | -0.28% | $48.72M | -16.56% | 10.33% |
| QXO | 0.38% | $6.51B | -35.95% | 0.00% |
| LITB | -0.47% | $35.48M | -75.45% | 0.00% |
| BCAN | 0.48% | $72.87M | -99.75% | 0.00% |
| UUU | 0.51% | $4.97M | -41.89% | 0.00% |
| EG | 0.65% | $15.92B | -8.98% | 2.02% |
| NEUE | -0.67% | $40.93M | -34.13% | 0.00% |
| KHC | -0.67% | $36.98B | -10.45% | 5.23% |
| CAH | 0.68% | $28.64B | +12.14% | 1.70% |
| MNR | 0.71% | $1.66B | -10.71% | 15.90% |
| LRN | -0.74% | $4.43B | +74.97% | 0.00% |
| LTM | -0.77% | $8.51B | -100.00% | <0.01% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CBOE | -16.59% | $21.46B | +15.84% | 1.11% |
| HUSA | -15.90% | $16.69M | -11.56% | 0.00% |
| MCK | -12.56% | $78.15B | +35.51% | 0.42% |
| PULM | -12.09% | $19.83M | +202.98% | 0.00% |
| LMT | -10.09% | $126.40B | +18.99% | 2.36% |
| JNPR | -9.99% | $11.61B | +30.55% | 2.49% |
| CYD | -9.48% | $364.46M | -2.94% | 4.26% |
| TCTM | -9.20% | $8.10M | -42.99% | 0.00% |
| RNR | -8.41% | $13.74B | +23.09% | 0.58% |
| ZCMD | -8.06% | $2.80M | -88.67% | 0.00% |
| PGR | -7.80% | $149.10B | +57.29% | 0.45% |
| HIHO | -7.62% | $8.63M | 0.00% | 6.12% |
| FTNT | -7.37% | $69.59B | +72.67% | 0.00% |
| GIS | -7.01% | $34.85B | -2.91% | 3.78% |
| DOGZ | -6.73% | $614.77M | +1,372.26% | 0.00% |
| CHD | -6.43% | $27.18B | +19.50% | 1.03% |
| ACGL | -6.13% | $36.00B | +16.84% | 0.00% |
| CPB | -4.82% | $12.96B | +7.08% | 3.40% |
| VSTA | -4.54% | $204.94M | -39.33% | 0.00% |
| WMT | -4.41% | $696.11B | +66.69% | 1.38% |
ETF's related to CRL
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| SMOT | 69.26% | $374.04M | 0.49% |
| FSMD | 68.67% | $583.89M | 0.15% |
| GSSC | 68.66% | $529.86M | 0.2% |
| PSC | 68.49% | $702.17M | 0.38% |
| NUSC | 68.24% | $1.27B | 0.31% |
| ESML | 67.94% | $1.90B | 0.17% |
| SMMD | 67.89% | $1.24B | 0.15% |
| TMSL | 67.86% | $288.12M | 0.55% |
| XSMO | 67.72% | $1.25B | 0.39% |
| JMEE | 67.56% | $1.51B | 0.24% |
| IJT | 67.53% | $6.64B | 0.18% |
| XJH | 67.53% | $248.84M | 0.12% |
| IJR | 67.31% | $90.05B | 0.06% |
| ISCG | 67.28% | $640.00M | 0.06% |
| VXF | 67.18% | $21.54B | 0.06% |
| EZM | 67.15% | $823.84M | 0.38% |
| PRFZ | 67.12% | $2.65B | 0.39% |
| SLYG | 67.08% | $3.69B | 0.15% |
| VB | 67.07% | $63.63B | 0.05% |
| SCHM | 67.05% | $11.59B | 0.04% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TPMN | 0.01% | $40.60M | 0.65% |
| HIGH | -0.02% | $302.78M | 0.51% |
| HDRO | -0.09% | $164.26M | 0.3% |
| PDBC | -0.47% | $4.40B | 0.59% |
| KCCA | -0.69% | $220.51M | 0.87% |
| BOXX | 0.83% | $4.43B | 0.1949% |
| GSG | -0.85% | $914.42M | 0.75% |
| AGZD | -1.08% | $142.76M | 0.23% |
| TBIL | 1.28% | $4.38B | 0.15% |
| COMT | -1.41% | $829.06M | 0.48% |
| CLOI | -1.72% | $715.40M | 0.4% |
| DBA | -1.77% | $755.88M | 0.93% |
| DBC | 1.78% | $1.39B | 0.87% |
| KRBN | 2.06% | $242.47M | 0.85% |
| ULST | -3.44% | $535.47M | 0.2% |
| XBIL | 3.97% | $637.70M | 0.15% |
| BCI | 4.02% | $1.20B | 0.26% |
| SOYB | -4.09% | $27.32M | 0.22% |
| GBIL | 4.10% | $5.60B | 0.12% |
| FTGC | 4.14% | $2.17B | 1.02% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -52.22% | $388.04M | 1.43% |
| VIXY | -33.32% | $195.31M | 0.85% |
| TAIL | -24.27% | $67.98M | 0.59% |
| USDU | -16.64% | $201.97M | 0.5% |
| UUP | -13.11% | $309.25M | 0.77% |
| EQLS | -11.25% | $76.08M | 1% |
| CTA | -11.20% | $350.27M | 0.78% |
| USCI | -9.85% | $185.47M | 1.07% |
| DBE | -9.73% | $50.13M | 0.77% |
| WEAT | -9.57% | $120.27M | 0.28% |
| DBO | -9.55% | $217.57M | 0.77% |
| JUCY | -8.75% | $324.29M | 0.6% |
| KMLM | -6.48% | $353.87M | 0.9% |
| CORN | -4.48% | $61.12M | 0.2% |
| UNG | -4.45% | $908.80M | 1.06% |
| SOYB | -4.09% | $27.32M | 0.22% |
| ULST | -3.44% | $535.47M | 0.2% |
| DBA | -1.77% | $755.88M | 0.93% |
| CLOI | -1.72% | $715.40M | 0.4% |
| COMT | -1.41% | $829.06M | 0.48% |
News
SeekingAlpha
Charles River Laboratories presents with optimistic growth expectations that seem a stretch given the business's current performance. See why CRL stock is a Hold.
Finnhub
Dozens of researchers across Canada, including renowned environmentalist David Suzuki, have joined a growing chorus of voices urging the federal government to halt the importation of an endangered...
Yahoo
Explore how Charles River's (CRL) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Yahoo
WILMINGTON, Mass., November 11, 2024--Charles River Laboratories to Present at UBS and Jefferies Conferences
Yahoo
Charles River Laboratories International ( NYSE:CRL ) Third Quarter 2024 Results Key Financial Results Revenue...
Yahoo
Q3 2024 Charles River Laboratories International Inc Earnings Call
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.